{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T02:44:42Z","timestamp":1761101082594,"version":"build-2065373602"},"reference-count":37,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,4,10]],"date-time":"2015-04-10T00:00:00Z","timestamp":1428624000000},"content-version":"vor","delay-in-days":1043,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["bbmt.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biology of Blood and Marrow Transplantation"],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1016\/j.bbmt.2011.11.017","type":"journal-article","created":{"date-parts":[[2011,11,21]],"date-time":"2011-11-21T13:43:08Z","timestamp":1321882988000},"page":"894-902","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Marrow versus Blood-Derived Stem Cell Grafts for Allogeneic Transplantation from Unrelated Donors in Patients with Active Myeloid Leukemia or Myelodysplasia"],"prefix":"10.1016","volume":"18","author":[{"given":"Hartmut","family":"Bertz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandros","family":"Spyridonidis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriele","family":"Ihorst","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monika","family":"Engelhardt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carsten","family":"Gr\u00fcllich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ralph","family":"W\u00e4sch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reinhard","family":"Marks","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00fcrgen","family":"Finke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbmt.2011.11.017_bib1","first-page":"3702","article-title":"Blood stem cells compared with bone marrow as a source of hematopoietic cells for allogeneic transplantation. IBMTR Histocompatibility and Stem Cell Sources Working Committee and the European Group for Blood and Marrow Transplantation (EBMT)","volume":"95","author":"Champlin","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2011.11.017_bib2","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1056\/NEJM200101183440303","article-title":"Transplantation of bone marrow as compared with peripheral-blood cells from HLA-identical relatives in patients with hematologic cancers","volume":"344","author":"Bensinger","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bbmt.2011.11.017_bib3","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1200\/JCO.2000.18.3.537","article-title":"Randomized trial of bone marrow versus lenograstim-primed blood cell allogeneic transplantation in patients with early-stage leukemia: a report from the Soci\u00e9t\u00e9 Fran\u00e7aise de Greffe de Moelle","volume":"18","author":"Blaise","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2011.11.017_bib4","doi-asserted-by":"crossref","first-page":"3685","DOI":"10.1200\/JCO.2001.19.16.3685","article-title":"Acute and chronic graft-versus-host disease after allogeneic peripheral-blood stem-cell and bone marrow transplantation: a meta-analysis","volume":"19","author":"Cutler","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2011.11.017_bib5","doi-asserted-by":"crossref","first-page":"4370","DOI":"10.1182\/blood.V99.12.4370","article-title":"Retrospective comparison of bone marrow and granulocyte colony-stimulating factor-mobilized peripheral blood progenitor cells for allogeneic stem cell transplantation using HLA identical sibling donors in myelodysplastic syndromes","volume":"99","author":"Guardiola","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2011.11.017_bib6","doi-asserted-by":"crossref","first-page":"5074","DOI":"10.1200\/JCO.2005.09.020","article-title":"Allogeneic peripheral blood stem-cell compared with bone marrow transplantation in the management of hematologic malignancies: an individual patient data meta-analysis of nine randomized trials","volume":"23","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2011.11.017_bib7","doi-asserted-by":"crossref","first-page":"4872","DOI":"10.1200\/JCO.2004.02.189","article-title":"Higher mortality after allogeneic peripheral-blood transplantation compared with bone marrow in children and adolescents: the Histocompatibility and Alternate Stem Cell Source Working Committee of the International Bone Marrow Transplant Registry","volume":"22","author":"Eapen","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2011.11.017_bib8","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/sj.thj.6200117","article-title":"Female donors influence transplant-related mortality and relapse incidence in male recipients of sibling blood and marrow transplants","volume":"2","author":"Gratwohl","year":"2001","journal-title":"Hematol J"},{"key":"10.1016\/j.bbmt.2011.11.017_bib9","doi-asserted-by":"crossref","first-page":"4255","DOI":"10.1182\/blood-2002-10-3263","article-title":"Donor CMV serologic status and outcome of CMV-seropositive recipients after unrelated donor stem cell transplantation: an EBMT megafile analysis","volume":"102","author":"Ljungman","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2011.11.017_bib10","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/sj.bmt.1705388","article-title":"Does younger donor age affect the outcome of reduced-intensity allogeneic hematopoietic stem cell transplantation for hematologic malignancies beneficially?","volume":"38","author":"Mehta","year":"2006","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2011.11.017_bib11","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/sj.bmt.1705195","article-title":"Donor age and degree of HLA matching have a major impact on the outcome of unrelated donor haematopoietic cell transplantation for chronic myeloid leukaemia","volume":"37","author":"Carreras","year":"2006","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2011.11.017_bib12","doi-asserted-by":"crossref","first-page":"2726","DOI":"10.1182\/blood.V99.8.2726","article-title":"Association of CD34 cell dose with hematopoietic recovery, infections, and other outcomes after HLA-identical sibling bone marrow transplantation","volume":"99","author":"Bittencourt","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2011.11.017_bib13","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/sj.thj.6200108","article-title":"Stem cell transplantation for chronic myeloid leukaemia: the role of infused marrow cell dose","volume":"2","author":"Pocock","year":"2001","journal-title":"Hematol J"},{"key":"10.1016\/j.bbmt.2011.11.017_bib14","doi-asserted-by":"crossref","first-page":"4226","DOI":"10.1182\/blood.V89.11.4226","article-title":"Transplantation of marrow cells from unrelated donors for treatment of high-risk acute leukemia: the effect of leukemic burden, donor HLA-matching, and marrow cell dose","volume":"89","author":"Sierra","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2011.11.017_bib15","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1038\/sj.bmt.1702606","article-title":"Matched-pair analysis of peripheral blood stem cells compared to marrow for allogeneic transplantation","volume":"26","author":"Lickliter","year":"2000","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2011.11.017_bib16","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1182\/blood.V99.4.1130.h8001130_1130_1135","article-title":"Improved disease-free-survival after transplantation of peripheral blood stem cells as compared with bone marrow from HLA-identical unrelated donors in patients with first chronic phase chronic myeloid leukemia","volume":"99","author":"Elmaagacli","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2011.11.017_bib17","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1182\/blood.V98.6.1739","article-title":"No difference in graft-versus-host disease, relapse, and survival comparing peripheral stem cells to bone marrow using unrelated donors","volume":"98","author":"Remberger","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2011.11.017_bib18","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1182\/blood-2004-03-1000","article-title":"Increased risk of extensive chronic graft-versus-host disease after allogeneic peripheral blood stem cell transplantation using unrelated donors","volume":"105","author":"Remberger","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2011.11.017_bib19","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1016\/j.bbmt.2007.08.006","article-title":"Peripheral blood grafts from unrelated donors are associated with increased acute and chronic graft-versus-host disease without improved survival","volume":"13","author":"Eapen","year":"2007","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2011.11.017_bib20","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/S1470-2045(09)70225-6","article-title":"Standard graft-versus-host disease prophylaxis with or without anti-T-cell globulin in haematopoietic cell transplantation from matched unrelated donors: a randomised, open-label, multicentre phase 3 trial","volume":"10","author":"Finke","year":"2009","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.bbmt.2011.11.017_bib21","doi-asserted-by":"crossref","first-page":"4075","DOI":"10.1182\/blood.V96.13.4075","article-title":"Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: a Southwest Oncology Group\/Eastern Cooperative Oncology Group Study","volume":"96","author":"Slovak","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2011.11.017_bib22","first-page":"303","article-title":"Allogeneic bone marrow transplantation from unrelated donors using in\u00a0vivo anti-T-cell globulin","volume":"111","author":"Finke","year":"2000","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bbmt.2011.11.017_bib23","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1200\/JCO.2003.03.129","article-title":"Matched and mismatched allogeneic stem-cell transplantation from unrelated donors using combined graft-versus-host disease prophylaxis including rabbit anti-T lymphocyte globulin","volume":"21","author":"Finke","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2011.11.017_bib24","first-page":"825","article-title":"1994 Consensus Conference on Acute GVHD Grading","volume":"15","author":"Przepiorka","year":"1995","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2011.11.017_bib25","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/0002-9343(80)90380-0","article-title":"Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients","volume":"69","author":"Shulman","year":"1980","journal-title":"Am J Med"},{"key":"10.1016\/j.bbmt.2011.11.017_bib26","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.3324\/haematol.2009.006924","article-title":"Is mobilized peripheral blood comparable with bone marrow as a source of hematopoetic stem cells for allogeneic transplantation from\u00a0HLA-identical sibling donors? A case-control study","volume":"94","author":"Gallardo","year":"2009","journal-title":"Haematologica"},{"key":"10.1016\/j.bbmt.2011.11.017_bib27","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1016\/j.bbmt.2009.07.009","article-title":"Decision analysis of peripheral blood versus bone marrow hematopoietic stem cells for allogeneic hematopoietic cell transplantation","volume":"15","author":"Pidala","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2011.11.017_bib28","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/S1470-2045(10)70127-3","article-title":"Effect of graft source on unrelated donor haemopoietic stem-cell transplantation in adults with acute leukaemia: a retrospective analysis","volume":"11","author":"Eapen","year":"2010","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.bbmt.2011.11.017_bib29","doi-asserted-by":"crossref","first-page":"4288","DOI":"10.1182\/blood-2006-05-024042","article-title":"Long-term outcome of patients given transplants of mobilized blood or bone marrow: a report from the International Bone Marrow Transplant Registry and the European Group for Blood and Marrow Transplantation","volume":"108","author":"Schmitz","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2011.11.017_bib30","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S1470-2045(09)70352-3","article-title":"Long-term outcome and late effects in patients transplanted with mobilised blood or bone marrow: a randomised trial","volume":"11","author":"Friedrichs","year":"2010","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.bbmt.2011.11.017_bib31","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1007\/s12185-010-0581-1","article-title":"Peripheral blood stem cell versus bone marrow transplantation from HLA-identical sibling donors in patients with leukemia: a propensity score-based comparison from the Japan Society for Hematopoietic Stem Cell Transplantation registry","volume":"91","author":"Nagafuji","year":"2010","journal-title":"Int J Hematol"},{"key":"10.1016\/j.bbmt.2011.11.017_bib32","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1053\/bbmt.2002.v8.pm12234169","article-title":"Influence of cytogenetic abnormalities on outcome after allogeneic bone marrow transplantation for acute myeloid leukemia in first complete remission","volume":"8","author":"Chalandon","year":"2002","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2011.11.017_bib33","doi-asserted-by":"crossref","first-page":"4325","DOI":"10.1182\/blood-2002-03-0772","article-title":"Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and\u00a0Leukemia Group B (CALGB 8461)","volume":"100","author":"Byrd","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2011.11.017_bib34","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1182\/blood-2006-10-043299","article-title":"Impact of cytogenetics on outcome of matched unrelated donor hematopoietic stem cell transplantation for acute myeloid leukemia in first or second complete remission","volume":"110","author":"Tallman","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2011.11.017_bib35","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1038\/leu.2010.200","article-title":"Antithymocyte globulins and chronic graft-vs-host disease after myeloablative allogeneic stem cell transplantation from HLA-matched unrelated donors: a report from the Soci\u00e9te Fran\u00e7aise de Greffe de Moelle et de Th\u00e9rapie Cellulaire","volume":"24","author":"Mohty","year":"2010","journal-title":"Leukemia"},{"key":"10.1016\/j.bbmt.2011.11.017_bib36","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/sj.bmt.1705038","article-title":"Is it appropriate to offer allogeneic hematopoietic stem cell transplantation to patients with primary refractory acute myeloid leukemia?","volume":"36","author":"Song","year":"2005","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2011.11.017_bib37","first-page":"587","article-title":"BMT CTN 0201: a phase III randomized, multicenter trial comparing G-CSF mobilized peripheral blood stem cell with marrow transplantation from HLA compatible unrelated donors","volume":"2","year":"2004","journal-title":"Clin Adv Hematol Oncol"}],"container-title":["Biology of Blood and Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879111004952?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879111004952?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T14:40:46Z","timestamp":1761057646000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1083879111004952"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6]]},"references-count":37,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012,6]]}},"alternative-id":["S1083879111004952"],"URL":"https:\/\/doi.org\/10.1016\/j.bbmt.2011.11.017","relation":{},"ISSN":["1083-8791"],"issn-type":[{"type":"print","value":"1083-8791"}],"subject":[],"published":{"date-parts":[[2012,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Marrow versus Blood-Derived Stem Cell Grafts for Allogeneic Transplantation from Unrelated Donors in Patients with Active Myeloid Leukemia or Myelodysplasia","name":"articletitle","label":"Article Title"},{"value":"Biology of Blood and Marrow Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbmt.2011.11.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 American Society for Blood and Marrow Transplantation. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}